A forward-dated calendar of the decisions that move stocks — surfaced before the market prices them in.
An earnings calendar tells you when a company reports. Nothing tells you when a government is about to decide the company's fate — an FDA drug approval, a Medicare coverage ruling, a foreign mine licence — or when a debt wall comes due or an IPO lock-up frees up supply. The Catalyst Calendar is that feed: every dated, non-earnings catalyst across the market, merged into one uniform record, each scored for confidence and dated so precisely you can replay exactly what was known on any past day.
A dated binary the market is over- or under-pricing is a mispricing you can see coming. Fear builds into a known date; options richen; the outcome is a coin-flip the desk can handicap. We provide the WHEN. The desk decides the WHAT.
| Ticker | In | Type | Catalyst | Read |
|---|---|---|---|---|
| BUDA | 1d | IPO lock-up | IPO lock-up expiration (180d after 2026-01-08 IPO) | Upcoming |
| VERA | 1d | FDA · PDUFA | PDUFA goal date for atacicept (IgA Nephropathy in adults) | Pending |
| SRRK | 17d | Foreign · EMA | EMA CHMP opinion (est): Scholar Rock Holding Corp — Apitegr… | Developer |
| AURA | 56d | Clinical readout | topline readout — AURA12, Ph2 | Upcoming |
| NVCR | 76d | Device · PMA | FDA PMA decision (projected) — Tumor Treating Fields for br… | Projected |
| PCSC | 86d | CMS · Coverage | Medicare coverage PENDING — SimpleScreen CRC v1 [preliminar… | Pending |
| HUM | 86d | CMS · Star Ratings | Star-ratings LITIGATION: HUM v CMS (appeal) — ruling ~2026… | Litigation Pending |
| PEP | 0d | Debt maturity | Debt maturity: $113.0M fund-held par | Contractual |
Every row is the same shape — ticker, event type, date, days-until, confidence, status, plain-English headline, and the source it came from — so a screen can reason across a drug approval and a debt wall in a single pass.
Cross-sector by design — biotech is just where the flagship lives. Counts are live.
Corporate bond walls coming due — refinancing pressure, dated to the day.
When insider shares free up — a supply overhang with a known date.
PDUFA goal dates & advisory-committee meetings — the classic binary.
Forward trial data — the biggest, least-priced biotech make-or-break events.
The payer gate: will Medicare pay? Denials & restrictions flagged early.
FDA PMA approvals & advisory panels for device makers.
Non-US regulators US desks don't calendar — European drug opinions, Canadian mine & nuclear licences.
Annual insurer scores — a bonus-payment cliff for managed care.
Screen the entire optionable universe for dated binaries in one pass; size and time the book around days-until. A fast model can crank the whole list nightly.
Implied vol richens into a known event date. The calendar surfaces that date months ahead — the raw material for a volatility-risk-premium trade.
Never get blindsided by a coverage denial or a foreign approval buried in a filing footnote. Every catalyst a name faces, in one view.
Ask "what's coming for our book in the next N days?" and get every dated decision across every name — with a confidence on each date.
Every row carries its source date. Replay the calendar as it stood on any past day — so a signal can be tested, not just asserted.
A stated FDA date scores near-certain; a vague "data in 2027" scores low and carries a range. You always know how firm the date is.
New filings, press releases and regulator feeds flow in every night; the whole calendar serves through one thin query.